Skip to main content
Michael Herson, MD, Endocrinology, Clackamas, OR

Michael Kevin Herson MD

Diabetes, Lipid Metabolism


Physician

Join to View Full Profile
  • 10180 Se Sunnyside RdClackamas, OR 97015

  • Phone+1 503-652-2880

Dr. Herson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • I am a retired endocrinologist having worked at Northwest Permanente for over 25 years. I continue to teach at OHSU, work at the free clinic, do virtual consulting, and research.

Education & Training

  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1984 - 1985
  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterResidency, Internal Medicine, 1981 - 1984
  • Chicago Medical School at Rosalind Franklin University of Medicine and Science
    Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1981

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1982 - 2026
  • WA State Medical License
    WA State Medical License 1990 - 2026
  • OR State Medical License
    OR State Medical License 1991 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Portland Monthly Magazine Castle Connolly, 2011
  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
  • Top MD Consumers Checkbook
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Commonly Prescribed Osteoporosis Drug Associated with Very Low Risk of Serious Jaw Disease
    Commonly Prescribed Osteoporosis Drug Associated with Very Low Risk of Serious Jaw DiseaseFebruary 14th, 2011

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: